Loading…
Addus HomeCare Corporation is projected to rise to $140.72 by 2027, a +21% move from its current price of $116.68. ADUS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $115.07 | $116.74 | $118.44 | +0.05% |
| Aug 2 | $114.44 | $116.80 | $119.21 | +0.10% |
| Aug 3 | $113.97 | $116.86 | $119.81 | +0.15% |
| Aug 4 | $113.59 | $116.91 | $120.34 | +0.20% |
| Aug 5 | $113.26 | $116.97 | $120.81 | +0.25% |
| Aug 6 | $112.97 | $117.03 | $121.24 | +0.30% |
| Aug 7 | $112.70 | $117.09 | $121.65 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $112.70 | $117.09 | $121.65 | +0.35% |
| Week 2 | $111.33 | $117.50 | $124.02 | +0.71% |
| Week 3 | $110.37 | $117.92 | $125.98 | +1.06% |
| Week 4 | $109.63 | $118.33 | $127.72 | +1.42% |
| Week 5 | $109.03 | $118.75 | $129.34 | +1.77% |
| Week 6 | $108.53 | $119.17 | $130.85 | +2.13% |
| Week 7 | $108.10 | $119.59 | $132.30 | +2.49% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services.
The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals.
Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
Addus HomeCare Corporation (ADUS) is a healthcare company that provides home-based services through Personal Care, Hospice, and Home Health segments.
It is currently priced at $119.22 and has a market capitalization of $2.23B. It is ranked 1880 in market capitalization.
The stock’s 30-day technical picture shows bullish sentiment with RSI14 at 70, and moving averages at SMA50 for $98.99 and SMA200 for $105.37. The stock sits with a support level at $93.04 and a resistance level at $115.65, while trading in a 30-day range of $108.15 to $131.42.
The forecast suggests a path of higher prices over time, with 2026 average price at $119.22 and path to much higher levels by 2030–2050; near-term view is neutral to bullish depending on year, with growing upside in later years.
A major floor 27.5% below — a decisive break under it would weaken the trend.
The nearest floor, 19.5% below — buyers have tended to step in here.
Price is pressing into resistance (2.2% away) — a breakout level to watch.
A major ceiling 15.9% above — clearing it would confirm fresh momentum.
Key ADUS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ADUS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $117.05 | Sell | $116.73 | Sell |
| MA 10 | $114.79 | Buy | $114.89 | Buy |
| MA 20 | $111.52 | Buy | $111.27 | Buy |
| MA 50 | $100.97 | Buy | $104.88 | Buy |
| MA 100 | $98.78 | Buy | $102.78 | Buy |
| MA 200 | $105.45 | Buy | $104.27 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 68.26 | Neutral |
| Stoch RSI (14) | 11.86 | Buy |
| CCI (20) | 97.93 | Neutral |
| Williams %R (14) | -23.69 | Info |
| MACD (12,26,9) | 0.25 | Buy |
| ROC (12) | 7.54 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 76.31 | Neutral |
| TRIX (15) | 0.65 | Buy |
| Awesome (5,34) | 11.83 | Buy |
| Ultimate (7,14,28) | 66.70 | Neutral |
| Momentum (10) | 2.86 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 119.60 | Sell |
| ADX (14) | 41.96 | Buy |
| ATR (14) | 1.59 | Info |
Near term picture remains bullish in sentiment despite a flat start to the multi-year path. RSI14 is 70, indicating strong momentum.
The stock trades with SMA50 at $98.99 and SMA200 at $105.37, which can inform support and resistance context alongside the stated levels.
The 30-day price range spans $108.15 to $131.42, with a defined support at $93.04 and a resistance at $115.65. Annualized volatility is 30%, reflecting notable price movement potential over shorter horizons.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $88.49 | $116.68 | $157.56 | 0% | Neutral | |
| $115.38 | $140.72 | $179.34 | +21% | Bullish | |
| $124.96 | $155.30 | $203.36 | +33% | Bullish | |
| $140.21 | $176.97 | $236.73 | +52% | Bullish | |
| $172.59 | $220.80 | $300.72 | +89% | Bullish | |
| $200.67 | $259.88 | $359.56 | +123% | Bullish | |
| $209.46 | $274.33 | $384.99 | +135% | Bullish | |
| $231.45 | $306.34 | $435.50 | +163% | Bullish | |
| $243.94 | $326.08 | $469.13 | +179% | Bullish | |
| $249.35 | $336.49 | $489.50 | +188% | Bullish | |
| $383.38 | $539.64 | $822.79 | +363% | Bullish | |
| $793.60 | $1,198.12 | $1,958.40 | +927% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $88.49 | $116.68 | $135.81 | +0.00% |
| August 2026 | $100.62 | $117.32 | $139.42 | +0.55% |
| September 2026 | $104.16 | $122.15 | $146.52 | +4.11% |
| October 2026 | $106.24 | $125.16 | $151.24 | +2.46% |
| November 2026 | $106.11 | $125.48 | $152.54 | +0.26% |
| December 2026 | $108.63 | $128.90 | $157.56 | +2.73% |
Click any year to see its month-by-month ADUS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ADUS could reach as high as $157.56, with a base case around $116.68 and support toward $88.49 — roughly 0% from $116.68. Price action looks broadly range-bound.
Expect ADUS to range from $115.38 to $179.34 through 2027. The $140.72 average target implies a +21% move from current prices. That is up +21% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The ADUS price prediction for 2028 points to an average of $155.30 (low $124.96, high $203.36) — a potential gain of +33% on today's $116.68. Momentum favours further upside here.
In 2029, ADUS is projected to trade between $140.21 and $236.73, averaging $176.97 — a potential gain of +52% from today's $116.68. That is up +14% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Addus HomeCare Corporation's 2030 outlook centres on $220.80, within a $172.59 to $300.72 range. That is up +25% on the projected 2029 average. That marks a +89% change versus current levels. Momentum favours further upside here.
By 2031, ADUS could reach as high as $359.56, with a base case around $259.88 and support toward $200.67 — roughly +123% from $116.68. Buyers look set to stay in control over this stretch.
Expect ADUS to range from $209.46 to $384.99 through 2032. The $274.33 average target implies a +135% move from current prices. That is up +6% on the projected 2031 average. Momentum favours further upside here.
The ADUS price prediction for 2033 points to an average of $306.34 (low $231.45, high $435.50) — a potential gain of +163% on today's $116.68. Buyers look set to stay in control over this stretch.
In 2034, ADUS is projected to trade between $243.94 and $469.13, averaging $326.08 — a potential gain of +179% from today's $116.68. That is up +6% on the projected 2033 average. Momentum favours further upside here.
Addus HomeCare Corporation's 2035 outlook centres on $336.49, within a $249.35 to $489.50 range. That is up +3% on the projected 2034 average. That marks a +188% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ADUS could reach as high as $822.79, with a base case around $539.64 and support toward $383.38 — roughly +363% from $116.68. Momentum favours further upside here.
Expect ADUS to range from $793.60 to $1,958.40 through 2050. The $1,198.12 average target implies a +927% move from current prices. That is up +122% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ADUS today (≈ 8.570449 ADUS) could be worth
$10,268.38
+$9,268.38 (+927%) by 2050 · US Dollar
Based on the average projected ADUS price of $1,198.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ADUSwould be worth at today's price.
$1,000 invested in ADUS on Jul 30, 2025 (≈ 9.269559 ADUS) would be worth
$1,081.57
+$81.57 (+8.2%) today · 1.08× · US Dollar
Based on a ADUS entry price of $107.88 vs. today's $116.68.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $111.92 | $1,042.53 | +4.3% |
| 1 month ago | $100.47 | $1,161.34 | +16.1% |
| 3 months ago | $99.56 | $1,171.96 | +17.2% |
| 6 months ago | $103.48 | $1,127.56 | +12.8% |
| 1 year ago | $107.88 | $1,081.57 | +8.2% |
| All time (5.0y) ago | $85.11 | $1,370.93 | +37.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ADUS forecast.
Our base-case forecast reaches $230.00 around 2031.
Implied market cap at $230.00: $4.29B
The multi-year outlook shows gradual uplift beginning in 2027 and accelerating thereafter. The 2026 forecast has an average price of $119.22 with a neutral sentiment and 0% ROI, followed by a 2027 average of $142.89 with 19.9% ROI and neutral sentiment.
From 2028 onward, the forecast turns bullish with rising averages: 2028 $157.00 (31.7% ROI), 2029 $178.95 (50.1% ROI), and 2030 $221.74 (86% ROI). The bullish trend continues through 2031–2035, with 2031 $260.27 (118.3% ROI), 2032 $275.08 (130.7% ROI), 2033 $305.87 (156.6% ROI), 2034 $324.88 (172.5% ROI), and 2035 $335.13 (181.1% ROI).
Longer term, the forecast projects substantial upside: 2040 $533.14 (347.2% ROI) and 2050 $1,177.89 (888% ROI) with max prices of $812.91 and $1,925.41 respectively. These are estimates and not guarantees, and outcomes depend on market conditions and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $221.74 with a max of $302.03 and a min of $173.32, yielding an 86% ROI and bullish sentiment.
The outlook turns bullish from 2028 onward, with increasing average prices and double-digit to triple-digit ROI by 2030–2050. The 2026 average is $119.22 with 0% ROI and neutral sentiment, expanding to a 2030 average of $221.74 and an 86% ROI with bullish sentiment by 2030.
Yes. The 2030 max is $302.03 and the 2033 average is $305.87, both above $300, reflecting upside in the forecast path to 2030–2033.
The 30-day range is $108.15 to $131.42, with support at $93.04 and resistance at $115.65.
Addus HomeCare Corporation Community Discussion
0Share your Addus HomeCare Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.